NEW YORK (GenomeWeb News) — Genzyme will join an international public/private initiative to develop malaria drugs, the company said yesterday.
 
The company will work with the Medicines for Malaria Venture, MIT’s Broad Institute, and Harvard University to develop treatments by identifying compounds that the company claims offer a new approach to treating the disease.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.